Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medicago Inc MDCGF

Healthcare Biotechnology

Recent & Breaking News (GREY:MDCGF)

Medicago announces agreement to be acquired by Mitsubishi Tanabe Pharma in a transaction valued at $357M

Canada NewsWire July 12, 2013

Medicago announces agreement to be acquired by Mitsubishi Tanabe Pharma in a transaction valued at $357M

PR Newswire July 12, 2013

Immune Design and Medicago Announce License Agreement and Collaboration to Develop Novel Adjuvanted Pandemic Influenza Vaccines

PR Newswire June 27, 2013

Immune Design and Medicago Announce License Agreement and Collaboration to Develop Novel Adjuvanted Pandemic Influenza Vaccines

Canada NewsWire June 27, 2013

Medicago successfully produces plant-based Rotavirus VLP vaccine candidate

Canada NewsWire June 20, 2013

Medicago successfully produces plant-based Rotavirus VLP vaccine candidate

PR Newswire June 20, 2013

Medicago Granted Patent for Influenza Virus-Like Particles in Plants

Canada NewsWire June 17, 2013

Medicago Granted Patent for Influenza Virus-Like Particles in Plants

PR Newswire June 17, 2013

Medicago Receives Authorization from Health Canada and Commences Phase II Clinical Trial for an H5N1 Vaccine

Canada NewsWire June 11, 2013

Medicago Receives Authorization from Health Canada and Commences Phase II Clinical Trial for an H5N1 Vaccine

PR Newswire June 11, 2013

Medicago is First in the World to Report Positive Interim Results for its H7N9 Pre-Clinical Trial

Canada NewsWire June 6, 2013

Medicago is First in the World to Report Positive Interim Results for its H7N9 Pre-Clinical Trial

PR Newswire June 6, 2013

Medicago Announces 2013 First Quarter Financial Results

PR Newswire May 9, 2013

Medicago Announces 2013 First Quarter Financial Results

Canada NewsWire May 9, 2013

Medicago shares jump on vaccine announcement

Stockhouse Editorial May 8, 2013

Medicago successfully produces VLP vaccine candidate for H7N9 virus responsible for recent influenza outbreak in China

Canada NewsWire May 8, 2013

Medicago successfully produces VLP vaccine candidate for H7N9 virus responsible for recent influenza outbreak in China

PR Newswire May 8, 2013

Medicago Announces a $3.5 Million Private Placement

Canada NewsWire April 23, 2013

Medicago and IDRI Reports Positive Results for its Phase I Clinical Trial for an H5N1 Vaccine

Canada NewsWire April 17, 2013

Medicago and IDRI to present data at the World Vaccine Congress

Canada NewsWire April 9, 2013